AQR Arbitrage’s Moringa Acquisition Corp Warrant MACAW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-20,000
| Closed | -$2.2K | – | 615 |
|
|
2024
Q2 | $2.2K | Hold |
20,000
| – | – | ﹤0.01% | 537 |
|
|
2024
Q1 | $1.59K | Hold |
20,000
| – | – | ﹤0.01% | 581 |
|
|
2023
Q4 | $650 | Hold |
20,000
| – | – | ﹤0.01% | 673 |
|
|
2023
Q3 | $664 | Hold |
20,000
| – | – | ﹤0.01% | 773 |
|
|
2023
Q2 | $1.72K | Hold |
20,000
| – | – | ﹤0.01% | 872 |
|
|
2023
Q1 | $1.78K | Hold |
20,000
| – | – | ﹤0.01% | 1028 |
|
|
2022
Q4 | $2.12K | Hold |
20,000
| – | – | ﹤0.01% | 1117 |
|
|
2022
Q3 | $1K | Hold |
20,000
| – | – | ﹤0.01% | 1409 |
|
|
2022
Q2 | $2K | Hold |
20,000
| – | – | ﹤0.01% | 1461 |
|
|
2022
Q1 | $5K | Hold |
20,000
| – | – | ﹤0.01% | 1325 |
|
|
2021
Q4 | $194K | Hold |
20,000
| – | – | 0.01% | 1120 |
|
|
2021
Q3 | $12K | Hold |
20,000
| – | – | ﹤0.01% | 1139 |
|
|
2021
Q2 | $15K | Buy |
+20,000
| New | +$12.7K | ﹤0.01% | 1092 |
|
AQR Arbitrage's MACAW Position: Q3 2024 in Review
AQR Arbitrage sold out of Moringa Acquisition Corp Warrant (MACAW) in Q3 2024, closing a stake of 20,000 shares — an estimated $2.2K sold.
AQR Arbitrage first reported a position in MACAW in Q2 2021 and held it in 13 quarters. The position peaked at $194K in Q4 2021. 0 funds tracked by Wall St. Rank hold MACAW as of Q3 2024.
- AQR Arbitrage reported no remaining Moringa Acquisition Corp Warrant position as of Q3 2024 after selling out during the quarter.
- AQR Arbitrage sold 20,000 Moringa Acquisition Corp Warrant shares in Q3 2024, an estimated $2.2K.
- AQR Arbitrage first reported a position in Moringa Acquisition Corp Warrant in Q2 2021 and held it in 13 quarters.
- AQR Arbitrage's Moringa Acquisition Corp Warrant position peaked at $194K in Q4 2021.
- 0 funds tracked by Wall St. Rank held Moringa Acquisition Corp Warrant as of Q3 2024.
Based on AQR Arbitrage's 13F filing for Q3 2024, filed 14 Nov 2024.